Gastric ulcer and duodenal ulcer - A potassium chloride tablet or a bisphosphonate Factor
Last reviewed for CCPS 24 May 2007.
Investigative Documents
Medical Report - Drug Treatment - Gastric Ulcer and Duodenal Ulcer [MR9372]
Preliminary questions [37661]
there is some evidence that treatment with a potassium chloride tablet or a bisphosphonate may be a factor in the development or worsening of the condition under consideration.37663 the veteran has been treated with a potassium chloride tablet or a bisphosphonate at some time.
the veteran was treated with a potassium chloride tablet or a bisphosphonate for an illness or injury which is identifiable.37665 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and VEA service for gastric ulcer or duodenal ulcer.
37666 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and VEA service for the clinical onset of gastric ulcer or duodenal ulcer.
37669 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and eligible service for the clinical onset of gastric ulcer or duodenal ulcer.
or
37668 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and operational service for the clinical onset of gastric ulcer or duodenal ulcer.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened.37667 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and VEA service for the clinical worsening of gastric ulcer or duodenal ulcer.
37671 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and eligible service for the clinical worsening of gastric ulcer or duodenal ulcer.
or
37670 — the veteran has established the causal connection between treatment with a potassium chloride tablet or a bisphosphonate and operational service for the clinical worsening of gastric ulcer or duodenal ulcer.
Clinical onset and operational service [37668]
for the identified illness or injury, the veteran was treated with a potassium chloride tablet or a bisphosphonate within the seven days before the clinical onset of the condition under consideration.37676 — the identified illness or injury, for which the veteran was treated with a potassium chloride tablet or a bisphosphonate, is causally related to operational service.
Clinical onset and eligible service [37669]
for the identified illness or injury, the veteran was treated with a potassium chloride tablet or a bisphosphonate at the time of the clinical onset of the condition under consideration.37677 — the identified illness or injury, for which the veteran was treated with a potassium chloride tablet or a bisphosphonate, is causally related to eligible service.
Clinical worsening and operational service [37670]
for the identified illness or injury, the veteran was treated with a potassium chloride tablet or a bisphosphonate within the seven days before the clinical worsening of the condition under consideration.37676 — the identified illness or injury, for which the veteran was treated with a potassium chloride tablet or a bisphosphonate, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was treated with a potassium chloride tablet or a bisphosphonate, is causally related.Clinical worsening and eligible service [37671]
for the identified illness or injury, the veteran was treated with a potassium chloride tablet or a bisphosphonate at the time of the clinical worsening of the condition under consideration.37677 — the identified illness or injury, for which the veteran was treated with a potassium chloride tablet or a bisphosphonate, is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran was treated with a potassium chloride tablet or a bisphosphonate, is causally related.